InsidersTradesSigma
Track the ALS LIMITED share price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on AU AU, under the authority of ASX. Market capitalisation: €11.5bn. The latest transaction was filed on 2 July 2026 (Cease Substantial Holding). Among the most active insiders: Unknown Substantial Holder. Every trade is free.
Analysts rate ALS LIMITED Buy (bullish), based on 14 analysts. Average price target: A$24.07.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
ALS LIMITED is a company listed on the Australian Securities Exchange, specializing in analytical and testing services for various sectors, including mining and environmental.